US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 2.2000
  • -0.1000-4.35%
Close Mar 28 16:00 ET
  • 2.3100
  • +0.1100+5.00%
Post 17:03 ET
162.91MMarket Cap-1.79P/E (TTM)

Perspective Therapeutics Key Stats

Perspective Therapeutics Q4 2024 Earnings Date

Currency:USDMar 26, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
EPS
-0.24
-0.61
-0.37
Miss Est.
+73.17%
+93.30%
-152.69%
Net Income
--
-40.17M
--
-62.79%
Strong Buy

Mar 28, 2025

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 153.960K--
--2025/Q1-- / 153.170K--
Mar 26, 20252024/Q4234.000K / 302.510K--
Nov 12, 20242024/Q3369.000K / 237.910K--
Aug 12, 20242024/Q2526.000K / 135.630K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 153.960K--
--2025/Q1-- / 153.170K--
Mar 26, 20252024/Q4234.000K / 302.510K--
Nov 12, 20242024/Q3369.000K / 237.910K--
Aug 12, 20242024/Q2526.000K / 135.630K--

Unlock Free Earnings Estimates

Perspective Therapeutics Earnings Reports

Read more

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.